Download PDF
Thromb Haemost 1998; 80(04): 702-703
DOI: 10.1055/s-0037-1615445
Letters to the Editor
Schattauer GmbH

Retinal Vein Occlusion and Inherited Conditions Predisposing to Thrombophilia

Rosina Albisinni
1   From the Departments of Clinical and Experimental Medicine, Naples, Italy
,
Antonio Coppola
1   From the Departments of Clinical and Experimental Medicine, Naples, Italy
,
Marcello Loffredo
1   Opthalmology, University of Naples “Federico II”, Naples, Italy
,
Anna Maria Cerbone
1   From the Departments of Clinical and Experimental Medicine, Naples, Italy
,
Giovanni Di Minno
1   From the Departments of Clinical and Experimental Medicine, Naples, Italy
,
Giovanni Maria Greco
1   Opthalmology, University of Naples “Federico II”, Naples, Italy
› Author Affiliations
Further Information

Publication History

Received 03 February 1998

Accepted after revision 09 June 1998

Publication Date:
08 December 2017 (online)

    Permissions and Reprints

 

 

  • References

  • 1 Appiah AP, Trempe CL. Risk factors associated with branch vs. central retinal vein occlusion. Ann Ophtalmol 1989; 21: 153-7.
    PubMedGoogle Scholar
  • 2 Dodson PM, Kubicki AS, Taylor KG, Kritzinger EE. Medical conditions underlying recurrence of retinal vein occlusion. Br J Ophtalmol 1985; 69: 493-6.
    CrossrefPubMedGoogle Scholar
  • 3 Arend O, Renky A, Jung F, Kiesewetter H, Reim M, Wolf S. Role of rheologic factors in patients with acute central retinal vein occlusion. Ophtalmology 1996; 103: 80-6.
    CrossrefPubMedGoogle Scholar
  • 4 Williamson TH, Rumley A, Lowe GDO. Blood viscosity, coagulation and activated protein C resistance in central retinal vein occlusion: a population controlled study. Br J Ophtalmol 1996; 80: 203-8.
    CrossrefPubMedGoogle Scholar
  • 5 Bandello F, Viganò D’Angelo S, Parlavecchia M, Tavola A, Della Valle P, Brancato R, D’Angelo A. Hypercoagulability and high lipoprotein (a) levels in patients with central retinal vein occlusion. Thromb Haemost 1994; 72: 39-43.
    PubMedGoogle Scholar
  • 6 Dahlbäck B. Inherited thrombophilia: resistance to activated protein C as a pathogenic factor of venous thromboembolism. Blood 1995; 85: 607-14.
    PubMedGoogle Scholar
  • 7 Bertina RM, Koeleman BPC, Koster T, Rosendaal FR, Driven RJ, De Ronde H, Van der Velden PA, Reitsma PH. Mutation in blood coagulation factor V associated with resistence to activated protein C. Nature 1994; 369: 64-7.
    CrossrefPubMedGoogle Scholar
  • 8 Poort SW, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3’-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and in increase in venous thombosis. Blood 1996; 88: 3698-703.
    PubMedGoogle Scholar
  • 9 Hillarp A, Zöller B, Svensson PJ, Dahlbäck B. The 20210A allele of the prothrombin gene is a common risk factor among Swedish outpatients with verified deep venous thrombosis. Thromb Haemost 1997; 78: 990-2.
    Article in Thieme ConnectPubMedGoogle Scholar